PTC Therapeutics
PTCT
PTCT
201 hedge funds and large institutions have $2.93B invested in PTC Therapeutics in 2024 Q3 according to their latest regulatory filings, with 30 funds opening new positions, 71 increasing their positions, 69 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
201
Holders Change
+4
Holders Change %
+2.03%
% of All Funds
2.91%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.06%
New
30
Increased
71
Reduced
69
Closed
26
Calls
$5.68M
Puts
$2.51M
Net Calls
+$3.17M
Net Calls Change
+$3.9M
Top Buyers
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
+$20.4M |
| 2 |
AC
Armistice Capital
New York
|
+$10.1M |
| 3 |
PAI
Palo Alto Investors
Palo Alto,
California
|
+$9.81M |
| 4 |
BlackRock
New York
|
+$7.83M |
| 5 |
Squarepoint
New York
|
+$7.75M |
Top Sellers
| 1 |
Janus Henderson Group
London,
United Kingdom
|
-$41.2M |
| 2 |
CSS
Cubist Systematic Strategies
Stamford,
Connecticut
|
-$15.5M |
| 3 |
Morgan Stanley
New York
|
-$13.3M |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
-$11.7M |
| 5 |
Renaissance Technologies
New York
|
-$10.4M |
